Who are we?
AxxessBio was created in Singapore in 2011 by professional executives from the Biotech industry. Currently, we are present in Singapore, Malaysia, Brunei, Hong-Kong, Macau, Philippines and Thailand. Through our network of partners, we can distribute your products and drive a well-planned growth of your products in Asia thanks to :
- our technical expertise,
- our regulatory acumen,
- our compliance mindset,
- and our commercial agility.
AxxessBio is well-positioned to enable your company to accelerate access to patients and to payment streams with minimal investment.
AxxessBio’s expansion is leading to more direct geographic coverage. We aim to provide solutions particularly in the areas of Hematology, Oncology, Nephrology and rare diseases.
If you believe in innovative approaches for patients individualized solutions. Join us! Discover what it means to be “patient driven”.Apply
AxxessBio builds various Strategic Alliances to bring your products to patients in need in Asia, DKSH is our key partner for logistics services.
DKSH is the leading Market Expansion Services Group with a focus on Asia. They offer a wide range of Market Expansion Services from product registration, marketing and sales to physical distribution.
We signed a Strategic Alliance with DKSH in January 2012 to provide a comprehensive service for healthcare product in a large geography in Asia.
ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore.
Our ADDED Values
Relationships with Key Opinion Leaders
High level relationships with Key Opinion Leaders in the field of Endocrinology, Pediatrics, Nephrology, Infectious diseases, Human Genetics, Hematology and Oncology…
Relationships with patient associations
A successful track record in Asia in helping to build-up patient associations and advocacy groups for rare diseases
Relationships with government
Mature and sustainable relationships with government and non-government stakeholders in full compliance with American, European and local anti-bribery / anti corruption legislation and policies.